Pediatric Portal Interventions

Pediatric portal interventions pose different challenges when compared with those in adults. Furthermore, the workup and clinical management of children in the preoperative, operative, and postoperative periods are different from that of the adult population with liver disease requiring a portal intervention. Decision-making processes should be executed differently in children based on these factors. Often, pediatric patients requiring portal interventions are transferred to larger academic institutions with standalone children's hospitals and child-specific liver transplant initiatives. Thus, smaller institutions may not have the personnel or systems in place to properly perform these interventions. As an alternative to surgical splenorenal or mesocaval shunts, transjugular intrahepatic portosystemic shunts (TIPS) may be performed in children to manage variceal bleeding and ascites. Other portal interventions including portal vein recanalization, variceal sclerotherapy, splenic embolization, and congenital portosystemic shunt embolization may be performed as well.[1]

• References

• 1 Srinivasa RN, Dasika NL, Jo A, Saad WEA. Endovascular management of portal hypertension complications in the pediatric population. In: Saad WEA. , ed. Portal Hypertension: Imaging, Diagnosis, and Endovascular Management. 3rd ed. New York, NY: Thieme; 2017: 225-232
• 2 Heyman MB, LaBerge JM, Somberg KA. , et al. Transjugular intrahepatic portosystemic shunts (TIPS) in children. J Pediatr 1997; 131 (06) 914-919
• 3 Saad WE, Anderson CL, Patel RS. , et al. Management of gastric varices in the pediatric population with balloon-occluded retrograde transvenous obliteration (BRTO) utilizing sodium tetradecyl sulfate foam sclerosis with or without partial splenic artery embolization. Cardiovasc Intervent Radiol 2015; 38 (01) 236-241
• 4 Saad WE, Davies MG, Lee DE. , et al. Transjugular intrahepatic portosystemic shunt in a living donor left lateral segment liver transplant recipient: technical considerations. J Vasc Interv Radiol 2005; 16 (06) 873-877
• 5 Saad WE, Darwish WM, Davies MG, Waldman DL. Transjugular intrahepatic portosystemic shunts in liver transplant recipients for management of refractory ascites: clinical outcome. J Vasc Interv Radiol 2010; 21 (02) 218-223
• 6 Saad WE, Darwish WM, Davies MG. , et al. Transjugular intrahepatic portosystemic shunts in liver transplant recipients: technical analysis and clinical outcome. AJR Am J Roentgenol 2013; 200 (01) 210-218
• 7 Waits SA, Wojcik BM, Cai S, Mathur AK, Englesbe MJ. Portal vein thrombosis and outcomes for pediatric liver transplant candidates and recipients in the United States. Liver Transpl 2011; 17 (09) 1066-1072
• 8 Chick JFB, Jo A, Dasika N, Saad WE, Srinivasa RN. Transsplenic endovascular recanalization and stenting of a completely occluded portal vein with jejunal variceal embolization in a pediatric liver transplant recipient. Pediatr Radiol 2017; 47 (08) 1012-1015
• 9 Saad WE, Madoff DC. Percutaneous portal vein access and transhepatic tract hemostasis. Semin Intervent Radiol 2012; 29 (02) 71-80
• 10 Saad WE, Kitanosono T, Koizumi J, Hirota S. The conventional balloon-occluded retrograde transvenous obliteration procedure: indications, contraindications, and technical applications. Tech Vasc Interv Radiol 2013; 16 (02) 101-151
• 11 Alonso J, Sierre S, Lipsich J, Questa H, Faella H, Moguillansky S. Endovascular treatment of congenital portal vein fistulas with the Amplatzer occlusion device. J Vasc Interv Radiol 2004; 15 (09) 989-993
• 12 Florio F, Nardella M, Balzano S, Giacobbe A, Perri F. Congenital intrahepatic portosystemic shunt. Cardiovasc Intervent Radiol 1998; 21 (05) 421-424
• 13 Gallego C, Miralles M, Marín C, Muyor P, González G, García-Hidalgo E. Congenital hepatic shunts. Radiographics 2004; 24 (03) 755-772
• 14 Konstas AA, Digumarthy SR, Avery LL. , et al. Congenital portosystemic shunts: imaging findings and clinical presentations in 11 patients. Eur J Radiol 2011; 80 (02) 175-181
• 15 Lautz TB, Tantemsapya N, Rowell E, Superina RA. Management and classification of type II congenital portosystemic shunts. J Pediatr Surg 2011; 46 (02) 308-314
• 16 Lee SA, Lee YS, Lee KS, Jeon GS. Congenital intrahepatic portosystemic venous shunt and liver mass in a child patient: successful endovascular treatment with an Amplatzer vascular plug (AVP). Korean J Radiol 2010; 11 (05) 583-586
• 17 Morikawa N, Honna T, Kuroda T. , et al. Resolution of hepatopulmonary syndrome after ligation of a portosystemic shunt in a pediatric patient with an Abernethy malformation. J Pediatr Surg 2008; 43 (02) e35-e38
• 18 Park JH, Cha SH, Han JK, Han MC. Intrahepatic portosystemic venous shunt. AJR Am J Roentgenol 1990; 155 (03) 527-528
• 19 Scalabre A, Gorincour G, Hery G, Gamerre M, Guys JM, de Lagausie P. Evolution of congenital malformations of the umbilical-portal-hepatic venous system. J Pediatr Surg 2012; 47 (08) 1490-1495
• 20 Stringer MD. The clinical anatomy of congenital portosystemic venous shunts. Clin Anat 2008; 21 (02) 147-157
• 21 Nacif LS, Paranaguá-Vezozzo DC, Galvão FHF. , et al. Significance of CT scan and color Doppler duplex ultrasound in the assessment of Abernethy malformation. BMC Med Imaging 2015; 15: 37
• 22 Chick JFB, Reddy SN, Yu AC. , et al. Three-dimensional printing facilitates successful endovascular closure of a Type II Abernethy malformation using an Amplatzer atrial septal occluder device. Ann Vasc Surg 2017; 43: 311.e15-311.e23